These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1828377)

  • 41. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp.
    O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1988; 14(10):617-9. PubMed ID: 2977587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.
    Mini E; Novelli A; Mazzei T; Periti P
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):256-60. PubMed ID: 2523807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of inoculum, medium and serum on the in-vitro susceptibility of coagulase-negative staphylococci to teicoplanin and vancomycin.
    Kennedy HF; Seal DV
    J Antimicrob Chemother; 1996 Jun; 37(6):1103-9. PubMed ID: 8836813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro teicoplanin-resistance in coagulase-negative staphylococci from patients with endocarditis and from a cardiac surgery unit.
    Moore EP; Speller DC
    J Antimicrob Chemother; 1988 Apr; 21(4):417-24. PubMed ID: 2967810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
    Pelitli TS; Cesur S; Kınıklı S; Irmak H; Demiröz AP; Karakoç E
    Mikrobiyol Bul; 2011 Oct; 45(4):758-61. PubMed ID: 22090309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
    Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
    Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiology of methicillin-resistance among Staphylococci strains isolated in risk units and effects of the vancomycin on the expression of methicillin-resistance].
    Roveta S; Tonoli E; Marchese A; Schito GC
    Infez Med; 2001 Jun; 9(2):82-9. PubMed ID: 12698020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A; Colao MG; Orsi A; Dei R; Giganti E; Parenti F
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
    Bouza E; Rodríguez-Créixems M; Muñoz P
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
    [No Abstract]   [Full Text] [Related]  

  • 52. Catheter-related bacteremia caused by methicillin-resistant coagulase negative staphylococci with elevated minimal inhibitory concentration for vancomycin.
    Castagnola E; Bandettini R; Lorenzi I; Caviglia I; Macrina G; Tacchella A
    Pediatr Infect Dis J; 2010 Nov; 29(11):1047-8. PubMed ID: 20581735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to vancomycin and teicoplanin: an emerging clinical problem.
    Johnson AP; Uttley AH; Woodford N; George RC
    Clin Microbiol Rev; 1990 Jul; 3(3):280-91. PubMed ID: 2143434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sensitivity to vancomycin and teicoplanin of coagulase-negative staphylococci isolated from clinical specimens].
    Młynarczyk G; Młynarczyk A; Luczak M; Jeljaszewicz J
    Med Dosw Mikrobiol; 1999; 51(1-2):17-23. PubMed ID: 10865426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin.
    Greenwood D; Bidgood K; Turner M
    J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
    Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
    Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [In vitro activity of glycopeptides on 114 coagulase-negative staphylococci: problems with the teicoplanin diffusion test, "alert" parameters indicating need for MIC determination].
    Jean-Pierre H; Rivière M; Darbas H; Boyer G
    Pathol Biol (Paris); 1993 Jun; 41(6):531-6. PubMed ID: 8247632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 59. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.
    Morrissey I; Seifert H; Canton R; Nordmann P; Stefani S; Macgowan A; Janes R; Knight D;
    J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.
    Boisson K; Thouverez M; Talon D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):660-5. PubMed ID: 12373498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.